18F-氟米索硝唑乏氧PET/CT诊断判读标准的制定及阅片者间信度、可重复性与性能验证
研究随机选取123例人乳头瘤病毒阳性口咽癌患者的123次18F-FDG PET/CT和134次18F-FMISO PET/CT扫描,由4名无18F-FMISO经验的核医学医师独立判读,以一位有20余年经验的医师判读为参考标准,制定并验证乏氧PET判读标准及培训方案。视觉评估在专门培训后平均灵敏度和特异度分别提高至97.6%和86.9%,阅片者间一致性达几乎完美(κ=0.86)。
要点
- 视觉评估以18F-FMISO摄取高于口底摄取定义为乏氧阳性。
- 专门培训后视觉评估平均灵敏度97.6%、特异度86.9%,κ=0.86。
- SUVmax比值阈值>1.2定量评估培训后平均灵敏度89.6%、特异度95.3%。
核心结论
- 无18F-FMISO乏氧PET阅片经验的核医学医师使用特定判读标准并接受专门培训后,阅片者间一致性大幅改善。
研究设计与样本
- 随机选取123例人乳头瘤病毒阳性口咽癌患者的123次18F-FDG PET/CT和134次18F-FMISO PET/CT扫描,患者来自一项II期试验。
- 4名无18F-FMISO经验的核医学医师独立判读,以一位有20余年18F-FMISO经验的核医学医师判读为参考标准。
- 在初始指导后和随后专门培训后分别评估判读性能。
主要发现
- 初始指导后视觉评估平均灵敏度77.3%、特异度80.9%,阅片者间一致性中等(κ=0.34)。
- 专门培训后视觉评估平均灵敏度提高至97.6%、特异度86.9%,一致性几乎完美(κ=0.86)。
- 初始指导后以估计最佳SUVmax比值阈值>1.2定义乏氧阳性进行定量评估,平均灵敏度56.8%、特异度95.9%,一致性显著(κ=0.66)。
- 专门培训后定量评估平均灵敏度提高至89.6%,平均特异度保持95.3%,一致性接近完美(κ=0.86)。
关键数值与推荐
- 视觉评估将18F-FMISO摄取大于口底摄取定义为乏氧阳性。
- 定量评估使用肿瘤与背景比值,估计最佳SUVmax比值阈值>1.2定义乏氧阳性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Tumor hypoxia, an integral biomarker to guide radiotherapy, can be imaged with 18F-fluoromisonidazole (18F-FMISO) hypoxia PET. One major obstacle to its broader application is the lack of standardized interpretation criteria. We sought to develop and validate practical interpretation criteria and a dedicated training protocol for nuclear medicine physicians to interpret 18F-FMISO hypoxia PET. Methods: We randomly selected 123 patients with human papillomavirus-positive oropharyngeal cancer enrolled in a phase II trial who underwent 123 18F-FDG PET/CT and 134 18F-FMISO PET/CT scans. Four independent nuclear medicine physicians with no 18F-FMISO experience read the scans. Interpretation by a fifth nuclear medicine physician with over 2 decades of 18F-FMISO experience was the reference standard. Performance was evaluated after initial instruction and subsequent dedicated training. Scans were considered positive for hypoxia by visual assessment if 18F-FMISO uptake was greater than floor-of-mouth uptake. Additionally, SUVmax was determined to evaluate whether quantitative assessment using tumor-to-background ratios could be helpful to define hypoxia positivity. Results: Visual assessment produced a mean sensitivity and specificity of 77.3% and 80.9%, with fair interreader agreement (κ = 0.34), after initial instruction. After dedicated training, mean sensitivity and specificity improved to 97.6% and 86.9%, with almost perfect agreement (κ = 0.86). Quantitative assessment with an estimated best SUVmax ratio threshold of more than 1.2 to define hypoxia positivity produced a mean sensitivity and specificity of 56.8% and 95.9%, respectively, with substantial interreader agreement (κ = 0.66), after initial instruction. After dedicated training, mean sensitivity improved to 89.6% whereas mean specificity remained high at 95.3%, with near-perfect interreader agreement (κ = 0.86). Conclusion: Nuclear medicine physicians without 18F-FMISO hypoxia PET reading experience demonstrate much improved interreader agreement with dedicated training using specific interpretation criteria.
引用
- Wray R, Mauguen A, Michaud L, et al. Development of 18F-Fluoromisonidazole Hypoxia PET/CT Diagnostic Interpretation Criteria and Validation of Interreader Reliability, Reproducibility, and Performance. J Nucl Med. 2024. PMID: 39266287. doi:10.2967/jnumed.124.267775
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。